Your browser doesn't support javascript.
loading
Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.
Amirthalingam, Gayatri; Bernal, Jamie Lopez; Andrews, Nick J; Whitaker, Heather; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Subbarao, Sathyavani; Ireland, Georgina; Baawuah, Frances; Linley, Ezra; Warrener, Lenesha; O'Brien, Michelle; Whillock, Corinne; Moss, Paul; Ladhani, Shamez N; Brown, Kevin E; Ramsay, Mary E.
Afiliación
  • Amirthalingam G; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom. gayatri.amirthalingam@phe.gov.uk.
  • Bernal JL; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Andrews NJ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Whitaker H; Statistics, Modelling and Economics Department, UK Health Security Agency, London, United Kingdom.
  • Gower C; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Stowe J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Tessier E; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Subbarao S; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Ireland G; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Baawuah F; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Linley E; Brondesbury Medical Centre, Kilburn, London, United Kingdom.
  • Warrener L; Sero-Epidemiolgy Unit, UK Health Security Agency, Manchester, United Kingdom.
  • O'Brien M; Virus Reference Department, UK Health Security Agency, London, United Kingdom.
  • Whillock C; Brondesbury Medical Centre, Kilburn, London, United Kingdom.
  • Moss P; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Ladhani SN; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, United Kingdom.
  • Brown KE; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, United Kingdom.
  • Ramsay ME; Paediatric Infectious Diseases Research Group, St. George's University of London, London, United Kingdom.
Nat Commun ; 13(1): 733, 2022 Feb 02.
Article en En | MEDLINE | ID: mdl-35110555
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido